92 related articles for article (PubMed ID: 20503411)
1. Is there a role for mammary stem cells in inflammatory breast carcinoma?: a review of evidence from cell line, animal model, and human tissue sample experiments.
Van Laere S; Limame R; Van Marck EA; Vermeulen PB; Dirix LY
Cancer; 2010 Jun; 116(11 Suppl):2794-805. PubMed ID: 20503411
[TBL] [Abstract][Full Text] [Related]
2. Mammary stem cells and breast cancer.
Molyneux G; Regan J; Smalley MJ
Cell Mol Life Sci; 2007 Dec; 64(24):3248-60. PubMed ID: 17955177
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer: origins and evolution.
Polyak K
J Clin Invest; 2007 Nov; 117(11):3155-63. PubMed ID: 17975657
[TBL] [Abstract][Full Text] [Related]
4. Progressive senescence programs induce intrinsic vulnerability to aging-related female breast cancer.
Bai H; Liu X; Lin M; Meng Y; Tang R; Guo Y; Li N; Clarke MF; Cai S
Nat Commun; 2024 Jun; 15(1):5154. PubMed ID: 38886378
[TBL] [Abstract][Full Text] [Related]
5. Evolution and Self-renewal of the Journal of Mammary Gland Biology and Neoplasia.
Hovey RC; Koledova Z
J Mammary Gland Biol Neoplasia; 2021 Sep; 26(3):217-220. PubMed ID: 34648096
[No Abstract] [Full Text] [Related]
6. Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis.
Ortiz-Soto G; Babilonia-Díaz NS; Lacourt-Ventura MY; Rivera-Rodríguez DM; Quiñones-Rodríguez JI; Colón-Vargas M; Almodóvar-Rivera I; Ferrer-Torres LE; Suárez-Arroyo IJ; Martínez-Montemayor MM
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902125
[TBL] [Abstract][Full Text] [Related]
7. MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer.
Manai M; ELBini-Dhouib I; Finetti P; Bichiou H; Reduzzi C; Aissaoui D; Ben-Hamida N; Agavnian E; Srairi-Abid N; Lopez M; Amri F; Guizani-Tabbane L; Rahal K; Mrad K; Manai M; Birnbaum D; Mamessier E; Cristofanilli M; Boussen H; Kharrat M; Doghri R; Bertucci F
Cells; 2022 Sep; 11(18):. PubMed ID: 36139501
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in Molecular Classification and Pathogenesis of Breast Tumors.
Richard V; Davey MG; Annuk H; Miller N; Dwyer RM; Lowery A; Kerin MJ
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771496
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative Aspect of Benzimidazole Derivatives' Activity and Their Impact on NF-κB Expression.
Błaszczak-Świątkiewicz K
Molecules; 2019 Oct; 24(21):. PubMed ID: 31671914
[TBL] [Abstract][Full Text] [Related]
10. Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium.
Devi GR; Hough H; Barrett N; Cristofanilli M; Overmoyer B; Spector N; Ueno NT; Woodward W; Kirkpatrick J; Vincent B; Williams KP; Finley C; Duff B; Worthy V; McCall S; Hollister BA; Palmer G; Force J; Westbrook K; Fayanju O; Suneja G; Dent SF; Hwang ES; Patierno SR; Marcom PK
J Cancer; 2019; 10(15):3344-3351. PubMed ID: 31293637
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network.
Valeta-Magara A; Gadi A; Volta V; Walters B; Arju R; Giashuddin S; Zhong H; Schneider RJ
Cancer Res; 2019 Jul; 79(13):3360-3371. PubMed ID: 31043378
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells.
Oladapo HO; Tarpley M; Sauer SJ; Addo KA; Ingram SM; Strepay D; Ehe BK; Chdid L; Trinkler M; Roques JR; Darr DB; Fleming JM; Devi GR; Williams KP
Cancer Lett; 2017 Dec; 411():136-149. PubMed ID: 28965853
[TBL] [Abstract][Full Text] [Related]
13. Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer.
Noman AS; Uddin M; Chowdhury AA; Nayeem MJ; Raihan Z; Rashid MI; Azad AK; Rahman ML; Barua D; Sultana A; Shirin A; Ferdous J; Parag RR; Rahman SM; Mahmud MR; Jerin CS; Jahan N; Siddiqua A; Ara T; Sabur EB; Alam SS; Baidya S; Akther S; Rahman MZ; Banu T; Murugan AK; Sabri S; Islam SMS; Karakas B; Aboussekhra A; Yeger H; Farhat WA; Islam SS
Sci Rep; 2017 May; 7(1):1796. PubMed ID: 28496132
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies.
Arora J; Sauer SJ; Tarpley M; Vermeulen P; Rypens C; Van Laere S; Williams KP; Devi GR; Dewhirst MW
Oncotarget; 2017 Apr; 8(16):25848-25863. PubMed ID: 28460441
[TBL] [Abstract][Full Text] [Related]
15. Intravascular emboli is an independent risk factor for the prognosis of stage III colorectal cancer patients after radical surgery.
Pei Q; Zhu H; Tan F; Yu N; Zhou Z; Zhou Y; Song X; Li Y; Tao Y; Zhang S; Li L; Li Q; Pei H
Oncotarget; 2016 Aug; 7(35):57268-57276. PubMed ID: 27528226
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.
Lacerda L; Debeb BG; Smith D; Larson R; Solley T; Xu W; Krishnamurthy S; Gong Y; Levy LB; Buchholz T; Ueno NT; Klopp A; Woodward WA
Breast Cancer Res; 2015 Mar; 17(1):42. PubMed ID: 25887413
[TBL] [Abstract][Full Text] [Related]
17. High-density and very-low-density lipoprotein have opposing roles in regulating tumor-initiating cells and sensitivity to radiation in inflammatory breast cancer.
Wolfe AR; Atkinson RL; Reddy JP; Debeb BG; Larson R; Li L; Masuda H; Brewer T; Atkinson BJ; Brewster A; Ueno NT; Woodward WA
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1072-80. PubMed ID: 25832697
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.
Jansen MP; Sas L; Sieuwerts AM; Van Cauwenberghe C; Ramirez-Ardila D; Look M; Ruigrok-Ritstier K; Finetti P; Bertucci F; Timmermans MM; van Deurzen CH; Martens JW; Simon I; Roepman P; Linn SC; van Dam P; Kok M; Lardon F; Vermeulen PB; Foekens JA; Dirix L; Berns EM; Van Laere S
Mol Oncol; 2015 Jun; 9(6):1218-33. PubMed ID: 25771305
[TBL] [Abstract][Full Text] [Related]
19. Targeting the NFκB signaling pathways for breast cancer prevention and therapy.
Wang W; Nag SA; Zhang R
Curr Med Chem; 2015; 22(2):264-89. PubMed ID: 25386819
[TBL] [Abstract][Full Text] [Related]
20. EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer.
Debeb BG; Gong Y; Atkinson RL; Sneige N; Huo L; Gonzalez-Angulo AM; Hung MC; Valero V; Ueno NT; Woodward WA
J Exp Clin Cancer Res; 2014 Jul; 33(1):58. PubMed ID: 25051981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
